SEC Info - Molecular Data Inc. - ‘6-K’ for 4/30/21

SEC Info℠

Home

Help

Please Sign In

Molecular Data Inc. – ‘6-K’ for 4/30/21

On: Tuesday, 4/13/21, at 4:05pm ET · For: 4/30/21 · Accession #: 1104659-21-49752 · File #: 1-39167

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/13/21  Molecular Data Inc.               6-K         4/30/21    3:334K                                   Toppan Merrill/FA

Current, Quarterly or Annual Report by a Foreign Issuer — Form 6-K — SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 6-K         Current, Quarterly or Annual Report by a Foreign    HTML     14K 
                Issuer                                                           
 2: EX-99.1     Miscellaneous Exhibit                               HTML    178K 
 3: EX-99.2     Miscellaneous Exhibit                               HTML     71K

‘6-K’ — Current, Quarterly or Annual Report by a Foreign Issuer

This is an HTML Document rendered as filed. [ Alternative Formats ]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2021

Commission File Number: 001- 39167

Molecular Data Inc.

11/F, Building 15, 2177 Shenkun Road

Minhang District, Shanghai 201106

People’s Republic of China
(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

EXHIBIT INDEX

Exhibit No.		Description
99.1		Securities Purchase Agreement
99.2		Registration Rights Agreement

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Molecular Data Inc.

By	:	/s/ *Steven Foo*
Name	:	Steven Foo
Title	:	Chief Financial Officer

Date: April 13, 2021

Dates Referenced Herein and Documents Incorporated by Reference

This ‘6-K’ Filing	Date	Other Filings

For Period end:	4/30/21	6-K
Filed on:	4/13/21
		List all Filings

6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/17/21  Molecular Data Inc.               424B5                  1:852K                                   Empire Filings/FA
 9/13/21  Molecular Data Inc.               424B5                  1:716K                                   Empire Filings/FA
 7/26/21  Molecular Data Inc.               424B7                  1:783K                                   Empire Filings/FA
 7/12/21  Molecular Data Inc.               424B5                  1:897K                                   Toppan Merrill/FA
 6/11/21  Molecular Data Inc.               F-3/A                  4:964K                                   Toppan Merrill/FA
 5/25/21  Molecular Data Inc.               F-3         5/24/21    7:799K                                   Toppan Merrill/FA

↑Top

Filing Submission 0001104659-21-049752 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)